Novartis Farma S.p.A., Novartis Farma S.p.A., Novartis Farmacéutica, S.A., Novartis Farma-Productos Farmacéuticos S.A., Novartis (Hellas) S.A.C.I., Novartis Hungary Ltd., Novartis Pharma B.V., Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma S.A.S, Novartis Pharmaceuticals S.R.L., Novartis Sverige AB
PolandAll drugs from this manufacturer
-
The medicine is used in adult patients to prevent the body's immune system from rejecting a transplanted kidney, heart, or liver.
Dosage form: tablets
Active substance Dosage everolimus 0.5 mg ATC: L04AA18
-
The medicine is used in adult patients to prevent the body's immune system from rejecting a transplanted kidney, heart, or liver.
Dosage form: tablets
Active substance Dosage everolimus 0.25 mg ATC: L04AA18
-
The medicine is used in adult patients to prevent the body's immune system from rejecting a transplanted kidney, heart, or liver.
Dosage form: tablets
Active substance Dosage everolimus 0.75 mg ATC: L04AA18
-
The medicine is used to treat high blood pressure in adults and children and adolescents (from 6 to 18 years), in adults following a recent heart attack, and in the treatment of symptomatic heart failure in adults.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 80 mg ATC: C09CA03
-
The medicine is used to treat high blood pressure in adults and children and adolescents (from 6 to 18 years), in adults following a recent heart attack, and in the symptomatic treatment of heart failure in adults.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg ATC: C09CA03
-
The medicine is used to treat acromegaly (a disease related to excess growth hormone), to relieve symptoms caused by excessive hormone secretion by the stomach, intestines, and pancreas, to treat intestinal neuroendocrine tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.
Dosage form: powder and solvent for preparation of suspension for injection
Active substance Dosage octreotide acetate 22.4 mg ATC: H01CB02